142 related articles for article (PubMed ID: 30083520)
1. siRNA Delivery for Control of Cyclin D1 and E2F1 Expression in Crohn's Disease.
Russo I; Carrizzo A; Bochicchio S; Piazza O; Lamberti G; Barba AA; Vecchione C; Zeppa P; Iovino P; Bucci C; Santonicola A; Ciacci C
Transl Med UniSa; 2017 Jul; 17():25-33. PubMed ID: 30083520
[TBL] [Abstract][Full Text] [Related]
2. siRNA Delivery for Control of Cyclin D1 and E2F1 Expression in Crohn's Disease.
Russo I; Carrizzo A; Bochicchio S; Piazza O; Lamberti G; Barba AA; Vecchione C; Zeppa P; Iovino P; Bucci C; Santonicola A; Ciacci C
Transl Med UniSa; 2017 Jul; 17():22-30. PubMed ID: 30050877
[TBL] [Abstract][Full Text] [Related]
3. Cyclin D1 Gene Silencing by siRNA in Ex Vivo Human Tissue Cultures.
Piazza O; Russo I; Bochicchio S; Barba AA; Lamberti G; Zeppa P; Crescenzo VD; Carrizzo A; Vecchione C; Ciacci C
Curr Drug Deliv; 2017; 14(2):246-252. PubMed ID: 27174173
[TBL] [Abstract][Full Text] [Related]
4. Dual TNF-α/Cyclin D1 Gene Silencing With an Oral Polymeric Microparticle System as a Novel Strategy for the Treatment of Inflammatory Bowel Disease.
Kriegel C; Amiji MM
Clin Transl Gastroenterol; 2011 Mar; 2(3):e2. PubMed ID: 23237848
[TBL] [Abstract][Full Text] [Related]
5. Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target.
Peer D; Park EJ; Morishita Y; Carman CV; Shimaoka M
Science; 2008 Feb; 319(5863):627-30. PubMed ID: 18239128
[TBL] [Abstract][Full Text] [Related]
6. Antisense to cyclin D1 inhibits vascular endothelial growth factor-stimulated growth of vascular endothelial cells: implication of tumor vascularization.
Yasui M; Yamamoto H; Ngan CY; Damdinsuren B; Sugita Y; Fukunaga H; Gu J; Maeda M; Takemasa I; Ikeda M; Fujio Y; Sekimoto M; Matsuura N; Weinstein IB; Monden M
Clin Cancer Res; 2006 Aug; 12(15):4720-9. PubMed ID: 16899623
[TBL] [Abstract][Full Text] [Related]
7. In vitro and ex vivo delivery of tailored siRNA-nanoliposomes for E2F1 silencing as a potential therapy for colorectal cancer.
Bochicchio S; Dapas B; Russo I; Ciacci C; Piazza O; De Smedt S; Pottie E; Barba AA; Grassi G
Int J Pharm; 2017 Jun; 525(2):377-387. PubMed ID: 28189855
[TBL] [Abstract][Full Text] [Related]
8. Vitamin C inhibits benzo[a]pyrene-induced cell cycle changes partly via cyclin D1/E2F pathway in human embryo lung fibroblasts.
Gao A; Liu BC; Shit XL; Huang CS; Jia XW; You BR; Ye M; Shen FH; Du HJ
Biomed Environ Sci; 2006 Jun; 19(3):239-44. PubMed ID: 16944783
[TBL] [Abstract][Full Text] [Related]
9. Crohn's Disease Fibroblasts Overproduce the Novel Protein KIAA1199 to Create Proinflammatory Hyaluronan Fragments.
Soroosh A; Albeiroti S; West GA; Willard B; Fiocchi C; de la Motte CA
Cell Mol Gastroenterol Hepatol; 2016 May; 2(3):358-368.e4. PubMed ID: 27981209
[TBL] [Abstract][Full Text] [Related]
10. miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop.
Deng M; Zeng C; Lu X; He X; Zhang R; Qiu Q; Zheng G; Jia X; Liu H; He Z
Cancer Lett; 2017 Sep; 403():175-185. PubMed ID: 28634044
[TBL] [Abstract][Full Text] [Related]
11. Variations in the low levels of cyclin D1/BCL1 have prognostic value in chronic lymphocytic leukemia.
Ravandi-Kashani F; O'Brien S; Manshouri T; Lerner S; Sim S; Dodd K; Kantarjian H; Freireich E; Keating M; Albitar M
Leuk Res; 2000 Jun; 24(6):469-74. PubMed ID: 10781679
[TBL] [Abstract][Full Text] [Related]
12. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of c-myc and Cyclin D1 genes by antisense oligodeoxy nucleotides inhibits the expression of E2F1 and in vitro growth of HepG2 and Morris 5123 liver cancer cells.
Simile MM; De Miglio MR; Muroni MR; Frau M; Asara G; Serra S; Muntoni MD; Seddaiu MA; Daino L; Feo F; Pascale RM
Carcinogenesis; 2004 Mar; 25(3):333-41. PubMed ID: 14604889
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the G1/S transition phase in mesangial cells by E2F1.
Inoshita S; Terada Y; Nakashima O; Kuwahara M; Sasaki S; Marumo F
Kidney Int; 1999 Oct; 56(4):1238-41. PubMed ID: 10504464
[TBL] [Abstract][Full Text] [Related]
15. Roles of E2F1 in mesangial cell proliferation in vitro.
Inoshita S; Terada Y; Nakashima O; Kuwahara M; Sasaki S; Marumo F
Kidney Int; 1999 Dec; 56(6):2085-95. PubMed ID: 10594784
[TBL] [Abstract][Full Text] [Related]
16. Involvement of cyclin D1 and E2F1 in intramedullary apoptosis in myelodysplastic syndromes.
Saberwal G; Broderick E; Janssen I; Shetty V; Alvi S; Lisak L; Venugopal P; Raza A; Mundle SD
J Hematother Stem Cell Res; 2003 Aug; 12(4):443-50. PubMed ID: 12965081
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease.
Singer II; Kawka DW; Schloemann S; Tessner T; Riehl T; Stenson WF
Gastroenterology; 1998 Aug; 115(2):297-306. PubMed ID: 9679035
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of cyclin D1, cyclin E, p21/waf1 and p27/kip1 in inflammatory bowel disease: correlation with other cell-cycle-related proteins (Rb, p53, ki-67 and PCNA) and clinicopathological features.
Ioachim EE; Katsanos KH; Michael MC; Tsianos EV; Agnantis NJ
Int J Colorectal Dis; 2004 Jul; 19(4):325-33. PubMed ID: 15060836
[TBL] [Abstract][Full Text] [Related]
19. Cyclic AMP negatively controls c-myc transcription and G1 cell cycle progression in p210 BCR-ABL transformed cells: inhibitory activity exerted through cyclin D1 and cdk4.
Williamson EA; Burgess GS; Eder P; Litz-Jackson S; Boswell HS
Leukemia; 1997 Jan; 11(1):73-85. PubMed ID: 9001421
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the immunoexpression of COX-1, COX-2 and p53 in Crohn's disease.
Romero M; Artigiani R; Costa H; Oshima CT; Miszputen S; Franco M
Arq Gastroenterol; 2008; 45(4):295-300. PubMed ID: 19148357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
